Major shareholder of Optorun Co.,Ltd.
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) and dividends retained by asset-management companies (less about 20% corporate tax), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| 株式会社歯愛メディカル 3540 · FY ending Dec 2024 |
Own name | 2,371,000 | 4.74% | ¥919 | ¥2.2B | ¥29.6M |
| Optorun Co.,Ltd. 6235 · FY ending Dec 2025 |
Own name | 838,000 | 2.10% | ¥1,910 | ¥1.6B | ¥45.3M |
| Kimoto Co.,Ltd. 7908 · FY ending Mar 2026 |
Own name | 1,630,000 | 3.73% | ¥261 | ¥425M | ¥11.4M |
| ERTH group Co., Ltd. 6072 · FY ending Mar 2026 · Director |
Own name | — | — | ¥960 | ¥0 | — |
| Year | Net worth | Pay | Dividends | Total income | Taxes (est.) | After tax (est.) |
|---|---|---|---|---|---|---|
| 2026 | ¥425M | — | ¥11.4M | ¥11.4M | ¥2.3M | ¥9.1M |
| 2025 | ¥1.6B | — | ¥45.3M | ¥45.3M | ¥9.2M | ¥36.1M |
Grouped by the calendar year of each company's fiscal year-end. Years in which the person was not among the top 10 shareholders of a company exclude that company.